Ignite Creation Date:
2024-05-05 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00426478
Status:
COMPLETED
Last Update Posted:
2008-08-22
First Post:
2007-01-23
Brief Title:
Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
The Comparison of the Antihypertensive Efficacy and Tolerability Between Valsartan Plus Hydrochlorothiazide 80mg125mg and Amlodipine 5mg in the Essential Hypertensive Patients
Status:
COMPLETED
Status Verified Date:
2008-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A double-blind active-controlled randomized trial to compare Valsartan plus Hydrochlorothiazide 80mg125mg and Amlodipine 5 mg
Study design 2 weeks washout 8 weeks treatment period
Study design 2 weeks washout 8 weeks treatment period
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None